Authors reported that patients administered oral THC experienced a “nine-fold greater reduction in opioid consumption” compared to controls.
Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.” Specifically, subjects who consumed cannabis daily “had about 50 percent lower odds of using illicit opioids every day [as] compared to cannabis non-users.”
Lehigh Valley NORML, and medical cannabis patients from across Pennsylvania, will hold the second in a series of monthly protests at the Department of Health (PaDOH) headquarters on Forster St. “Patients First: Fixing Medical Marijuana in PA” will commence on Wednesday November 13, 2019 from 08:30 AM-5:00 PM.
“Individuals who report having pain limiting that limits their daily activity see large health improvements. This is the strongest evidence that a group with a high probability of pain medication use sees large benefits from medical marijuana laws.”
To honor both those who have bravely served and those who still suffer due to federal cannabis laws, Nevada NORML will be hosting a unique event on Veteran’s Day. The virtual lobby day, a lobbying event done entirely through electronic means, will raise awareness of the many federal pieces of legislation that could benefit veterans.
Researchers concluded, “Our findings are consistent with prior surveys of American and Canadian marijuana users in which substitution of marijuana for opioids was prevalent due to better symptom management and fewer adverse and withdrawal effects.”
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs. “Our findings suggest that de facto medical use may be highly prevalent among adult use customers, and that access to an adult use cannabis market may influence individuals’ use of other medications,” authors concluded.
The administration of herbal cannabis is safe and effective in patients diagnosed with fibromyalgia, according to clinical data published this month in the Journal of Clinical Medicine.
Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs.
The administration of oral CBD reduces cue-induced cravings and anxiety in subjects with a history of heroin use, according to clinical data published in The American Journal of Psychiatry. Commenting on the study’s findings, NORML Deputy Director Paul Armentano said, “These conclusions add to the growing body of evidence that cannabis and its constituents represent an exit away from the use or abuse of other controlled substances rather than a supposed ‘gateway.'”